Note that human neuroblastoma cells treated with Aβ42 also exhibited proteasome inhibition and deregulation of the autophagic-lysosomal pathway, the latter confirmed by increased cathepsin activity [17]. This evidence concerns the gene CTSS and neuroblastoma.